[go: up one dir, main page]

MXPA04000814A - Derivados de 2h-piridazina-3-ona novedosos, composiciones farmaceuticas que contienen a los mismos y un procedimiento para la preparacion del ingrediente activo. - Google Patents

Derivados de 2h-piridazina-3-ona novedosos, composiciones farmaceuticas que contienen a los mismos y un procedimiento para la preparacion del ingrediente activo.

Info

Publication number
MXPA04000814A
MXPA04000814A MXPA04000814A MXPA04000814A MXPA04000814A MX PA04000814 A MXPA04000814 A MX PA04000814A MX PA04000814 A MXPA04000814 A MX PA04000814A MX PA04000814 A MXPA04000814 A MX PA04000814A MX PA04000814 A MXPA04000814 A MX PA04000814A
Authority
MX
Mexico
Prior art keywords
formula
hydrogen atom
group
novel
stands
Prior art date
Application number
MXPA04000814A
Other languages
English (en)
Inventor
Simig Gyula
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of MXPA04000814A publication Critical patent/MXPA04000814A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invencion se refiere a derivados de 2H-piridazina novedosos de la formula I, composiciones farmaceuticas que contienen a los mismos y a un procedimiento para la preparacion del ingrediente activo. Los compuestos novedosos tienen efecto neuroleptico y se pueden usar principalmente para el tratamiento de la esquizofrenia. En la formula I, R significa un atomo de hidrogeno o un grupo de alquilo de C1-4, X e Y representa, independientemente un atomo de hidrogeno, un atomo de halogeno o un grupo de la formula II, con la condicion de que cuando una de X e Y signifiquen siempre un grupo de la formula II, y el otro significa un atomo de hidrogeno o un atomo de halogeno, en donde en la formula II n tiene un valor de 1 o 2.
MXPA04000814A 2001-07-26 2002-07-24 Derivados de 2h-piridazina-3-ona novedosos, composiciones farmaceuticas que contienen a los mismos y un procedimiento para la preparacion del ingrediente activo. MXPA04000814A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0103063A HU225955B1 (en) 2001-07-26 2001-07-26 Novel 2h-pyridazin-3-one derivatives, process for their preparation, their use and pharmaceutical compositions containing them
PCT/HU2002/000072 WO2003010166A1 (en) 2001-07-26 2002-07-24 Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient

Publications (1)

Publication Number Publication Date
MXPA04000814A true MXPA04000814A (es) 2004-05-21

Family

ID=89979562

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04000814A MXPA04000814A (es) 2001-07-26 2002-07-24 Derivados de 2h-piridazina-3-ona novedosos, composiciones farmaceuticas que contienen a los mismos y un procedimiento para la preparacion del ingrediente activo.

Country Status (27)

Country Link
US (1) US7098210B2 (es)
EP (1) EP1417206B1 (es)
JP (1) JP4249012B2 (es)
KR (1) KR100909514B1 (es)
CN (1) CN1247571C (es)
AR (2) AR036248A1 (es)
AT (1) ATE466859T1 (es)
AU (1) AU2002321669B8 (es)
BR (1) BR0211440A (es)
CA (1) CA2453917C (es)
CY (1) CY1110240T1 (es)
CZ (1) CZ2004123A3 (es)
DE (1) DE60236294D1 (es)
DK (1) DK1417206T3 (es)
EA (1) EA006246B1 (es)
ES (1) ES2345541T3 (es)
HU (1) HU225955B1 (es)
MA (1) MA27867A1 (es)
MX (1) MXPA04000814A (es)
NO (1) NO326155B1 (es)
NZ (1) NZ531154A (es)
PL (1) PL206824B1 (es)
PT (1) PT1417206E (es)
SI (1) SI1417206T1 (es)
SK (1) SK552004A3 (es)
WO (1) WO2003010166A1 (es)
ZA (1) ZA200400482B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227255B1 (en) * 2002-04-26 2010-12-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Novel piperidine-alkyl-amino-pyridazine derivatives, pharmaceutical compositions containing the same and process for the preparation of the active ingredient
CN102663977B (zh) 2005-06-08 2015-11-18 伊格尼斯创新有限公司 用于驱动发光器件显示器的方法和系统
US9489891B2 (en) 2006-01-09 2016-11-08 Ignis Innovation Inc. Method and system for driving an active matrix display circuit
WO2007079572A1 (en) 2006-01-09 2007-07-19 Ignis Innovation Inc. Method and system for driving an active matrix display circuit
US9269322B2 (en) 2006-01-09 2016-02-23 Ignis Innovation Inc. Method and system for driving an active matrix display circuit
HUP0600555A3 (en) * 2006-07-03 2008-10-28 Egis Gyogyszergyar Nyrt Use of 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]izoxazol-3-yl)piperidin-1-yl]ethylamino}2-methyl-3(2h)-piridazinon for the production of pharmaceutical compositions for influencing cognitive functions and causing neuroprotective effect
CN102057418B (zh) 2008-04-18 2014-11-12 伊格尼斯创新公司 用于发光器件显示器的系统和驱动方法
CA2637343A1 (en) 2008-07-29 2010-01-29 Ignis Innovation Inc. Improving the display source driver
US9370075B2 (en) 2008-12-09 2016-06-14 Ignis Innovation Inc. System and method for fast compensation programming of pixels in a display
US8497828B2 (en) 2009-11-12 2013-07-30 Ignis Innovation Inc. Sharing switch TFTS in pixel circuits
CA2687631A1 (en) 2009-12-06 2011-06-06 Ignis Innovation Inc Low power driving scheme for display applications
CA2696778A1 (en) 2010-03-17 2011-09-17 Ignis Innovation Inc. Lifetime, uniformity, parameter extraction methods
US20140368491A1 (en) 2013-03-08 2014-12-18 Ignis Innovation Inc. Pixel circuits for amoled displays
US9351368B2 (en) 2013-03-08 2016-05-24 Ignis Innovation Inc. Pixel circuits for AMOLED displays
US9886899B2 (en) 2011-05-17 2018-02-06 Ignis Innovation Inc. Pixel Circuits for AMOLED displays
WO2012164474A2 (en) 2011-05-28 2012-12-06 Ignis Innovation Inc. System and method for fast compensation programming of pixels in a display
US9747834B2 (en) 2012-05-11 2017-08-29 Ignis Innovation Inc. Pixel circuits including feedback capacitors and reset capacitors, and display systems therefore
US9336717B2 (en) 2012-12-11 2016-05-10 Ignis Innovation Inc. Pixel circuits for AMOLED displays
US9786223B2 (en) 2012-12-11 2017-10-10 Ignis Innovation Inc. Pixel circuits for AMOLED displays
WO2014124755A1 (de) 2013-02-18 2014-08-21 Jürgen Von Der Ohe Verfahren und vorrichtung zum kaltstrahlreinigen
CA2894717A1 (en) 2015-06-19 2016-12-19 Ignis Innovation Inc. Optoelectronic device characterization in array with shared sense line
US9721505B2 (en) 2013-03-08 2017-08-01 Ignis Innovation Inc. Pixel circuits for AMOLED displays
CA2873476A1 (en) 2014-12-08 2016-06-08 Ignis Innovation Inc. Smart-pixel display architecture
CA2886862A1 (en) 2015-04-01 2016-10-01 Ignis Innovation Inc. Adjusting display brightness for avoiding overheating and/or accelerated aging
US10373554B2 (en) 2015-07-24 2019-08-06 Ignis Innovation Inc. Pixels and reference circuits and timing techniques
CA2898282A1 (en) 2015-07-24 2017-01-24 Ignis Innovation Inc. Hybrid calibration of current sources for current biased voltage progra mmed (cbvp) displays
US10657895B2 (en) 2015-07-24 2020-05-19 Ignis Innovation Inc. Pixels and reference circuits and timing techniques
CA2908285A1 (en) 2015-10-14 2017-04-14 Ignis Innovation Inc. Driver with multiple color pixel structure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE62890B1 (en) * 1988-12-06 1995-03-08 Hafslund Nycomed Pharma New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure
IL117646A (en) * 1995-04-12 2000-06-01 Ferrer Int 7-¬3-¬4-(6-fluoro-1,2-benzisoxazole-3-YL)piperidin-1-YL¾propoxy¾3-alkyl-chromen-4-ones their preparation their uses and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
HUP0103063A2 (hu) 2003-02-28
ZA200400482B (en) 2005-05-25
SI1417206T1 (sl) 2010-09-30
JP4249012B2 (ja) 2009-04-02
JP2004538293A (ja) 2004-12-24
PL206824B1 (pl) 2010-09-30
CN1545513A (zh) 2004-11-10
US7098210B2 (en) 2006-08-29
DK1417206T3 (da) 2010-08-16
PT1417206E (pt) 2010-07-29
MA27867A1 (fr) 2006-05-02
NO20040268L (no) 2004-03-23
CN1247571C (zh) 2006-03-29
WO2003010166A1 (en) 2003-02-06
PL367447A1 (en) 2005-02-21
HUP0103063A3 (en) 2005-06-28
CZ2004123A3 (cs) 2004-05-12
HU0103063D0 (en) 2001-10-28
AR088808A2 (es) 2014-07-10
AU2002321669B2 (en) 2008-05-15
SK552004A3 (en) 2004-08-03
NZ531154A (en) 2005-09-30
CA2453917C (en) 2009-06-23
CY1110240T1 (el) 2015-01-14
EP1417206B1 (en) 2010-05-05
KR20040030862A (ko) 2004-04-09
AU2002321669A2 (en) 2003-02-17
KR100909514B1 (ko) 2009-07-27
AR036248A1 (es) 2004-08-25
EA200400223A1 (ru) 2004-12-30
CA2453917A1 (en) 2003-02-06
ATE466859T1 (de) 2010-05-15
ES2345541T3 (es) 2010-09-27
BR0211440A (pt) 2004-07-20
US20040171619A1 (en) 2004-09-02
EA006246B1 (ru) 2005-10-27
NO326155B1 (no) 2008-10-13
EP1417206A1 (en) 2004-05-12
HU225955B1 (en) 2008-01-28
DE60236294D1 (de) 2010-06-17
AU2002321669B8 (en) 2008-06-05
HK1067626A1 (en) 2005-04-15

Similar Documents

Publication Publication Date Title
MXPA04000814A (es) Derivados de 2h-piridazina-3-ona novedosos, composiciones farmaceuticas que contienen a los mismos y un procedimiento para la preparacion del ingrediente activo.
HRP20040317A2 (en) 1,8-naphthyridine derivatives as antidiabetics
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
GEP20094736B (en) Prodrugs of piperazine and substituted piperidine antiviral agents
CA2425560A1 (en) Anticholinergics, processes for preparing them and their use as pharmaceutical compositions
HRP20031003A2 (en) 4'-substituted nukleosides
PL358281A1 (en) Novel compounds
PL366198A1 (en) Novel compounds
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
MY140693A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
IL150986A0 (en) 1,2,3,4,- tetrahydroisoquinoline derivatives
AU2002239344A1 (en) Pyrazolopyridines
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
DE60112330D1 (en) Pyrazolopyridinderivate
YU87202A (sh) Derivati arilmetilamina koji se koriste kao inhibitori triptaze
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
MY147373A (en) Piperazine derivatives as antimalarial agents
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
IL159554A0 (en) Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
MXPA05004273A (es) Derivados de fenilalquil y piridilalquil piperazina.
MXPA04001773A (es) Derivados de 6,7-dihidroxitetrahidroisquinolinas 3-sustituidas parta uso como agentes antibacterianos.
IL151198A0 (en) Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.

Legal Events

Date Code Title Description
FG Grant or registration